Alex­is Borisy, Zach Wein­berg de­but $520M idea for a new biotech in­vest­ing mod­el

Alex­is Borisy and Zach Wein­berg first met when they were each lead­ing a com­pa­ny that they co-found­ed. Foun­da­tion Med­i­cine, where Borisy was found­ing CEO and lat­er chair­man, struck a part­ner­ship with Wein­berg’s Flat­iron Health — be­fore both com­pa­nies were ul­ti­mate­ly ac­quired by Roche.

Al­most a decade lat­er, they are team­ing up to launch a new kind of in­vest­ment mod­el that they hope will help a new gen­er­a­tion of biotech founders build bet­ter com­pa­nies — or, in their words, “free the founders.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER